A. An increased number of medications and higher doses of similar medications due to the greater extent of the thrombotic event B. Comparable medications and doses C. Fewer medications, because the initial management of STEMI is adequate enough to reduce long-term complications

A. Prasugrel and clopidogrel equally reduced cardiovascular events and increased bleeding risk B. Prasugrel had greater reduction of adverse cardiovascular events and increased bleeding risk C. Prasugrel had greater reduction of adverse cardiovascular events and decreased bleeding risk D. Prasugrel had lesser reduction of adverse cardiovascular events and decreased bleeding risk E. Prasugrel had lesser reduction of adverse cardiovascular events and increased bleeding risk

A. Less than 20% B. 20%-30% C. 31%-40% D. 41%-50% E. More than 50%

A. Optimizing medical therapies B. Reconciling medications at admission and discharge C. Patient/caregiver education at the time of discharge D. Patient follow-up to ensure medication adherence E. All of the above